COMP <GO>
AAPG vs LBRX // ENTERPRISE SCALE & MARKET CAP
Ascentage Pharma Group International American Depository Shares (NASDAQ) VS. LB Pharmaceuticals Inc (NASDAQ) • 15-METRIC TALLY: AAPG 1
— LBRX 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: AAPG
AAPG — Ascentage Pharma Group International American Depository Shares SUPERIOR
ROARABLE D • RQD 45/100
LAST: $13.48 (-0.59%) • MKT CAP: $1.27B
market-cap
$1.27B
LAST: $40.33 (+3.30%) • MKT CAP: $1.26B
market-cap
$1.26B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AAPG VS. LBRX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AAPG | LBRX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -8.40% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -2.72% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 2/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.1 | 49.6 | -12.50 | LBRX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $1.27B | $1.26B | $6.2M | AAPG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AAPG REV | LBRX REV | AAPG GROSS % | LBRX GROSS % | AAPG FCF | LBRX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $131.4M | — | — | — | -$35.3M |
| FY 2024 | — | $14.1M | — | — | — | -$53.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AAPG // BETA —
LBRX // BETA —